Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
8°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
99
100
Next >
Ascendis Pharma's Rare Dwarfism Candidate Shows Promise In Trial, FDA Submission Expected Next Year
September 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ASND
Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
September 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
RHHBY
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Upcoming In-Person FDA Meeting to Discuss CNM-Au8
September 16, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity
September 16, 2024
Via
MarketBeat
Exposures
COVID-19
Product Safety
Tickers
MRK
MRNA
FDA Registered OTC Hearing Aids & Saunas: Daily Use & Care Guide Released
September 13, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
NRx Pharmaceuticals NRXP: Prominently Featured in Psychiatrist.com; Article Titled "How NRx Could Upend the Fight Against Depression and Suicide"
September 11, 2024
Via
PRLog
Exposures
Product Safety
FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
September 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ZNTL
UPTX Top Trader | Fly: How to Double Your Investment in 12 Months
September 13, 2024
Via
Binary News Network
Topics
Product Recall
Exposures
Legal
Product Safety
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ATAI
CMPS
MBIO
NUMIF
FDA Approves First OTC Hearing Aid Software Compatible With Apple's AirPods Pro
September 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AAPL
North Fish USA Inc. Recalls Cold Smoked Capelin Due to Potential Botulism Risk
September 12, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Alnylam Stock Soars 65%: Find Out What’s Behind the Gains
September 12, 2024
Via
MarketBeat
Exposures
Product Safety
Tickers
ALNY
PFE
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
September 11, 2024
Via
Benzinga
Exposures
Product Safety
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
EPC
JNJ
KMB
PG
Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval
September 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
HIMS
LLY
NVO
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Names Seasoned Veteran as New EVP of Commercial Operations
September 10, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Reports on FDA Pre-IND Meeting to Advance Development of Lead Program
September 10, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
SILO
Viridian Therapeutics Discloses 'Exciting' Data From Experimental Thyroid Eye Disease Candidate, Says Data Met High Bars For Efficacy, Safety
September 10, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
VRDN
Purisys Activates Drug Master File for Nalmefene, Introducing New Solution for Acute Opioid Overdose Treatment
September 10, 2024
Via
Newsfile
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
September 10, 2024
Via
Benzinga
Exposures
Product Safety
Syntekabio Appoints Joonhyuk Choi, Former Target Health CEO, as Head of US Operations
September 10, 2024
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Volkswagen Recalls Every ID.4 SUV in U.S. for Door Malfunction Concerns
September 10, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
VLKAF
VWAGY
VWAPY
Building a Sustainable Future in Tech: Insights from Dominic Tria
September 10, 2024
Via
Zexprwire
Topics
Product Recall
Exposures
Legal
Product Safety
The Importance of Trust in Toronto’s Real Estate Market with Michelle Kam
September 10, 2024
Via
Zexprwire
Topics
Product Recall
Exposures
Legal
Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Preclinical Data Demonstrating TNX-801’s Single-Dose Immune Protection Against Mpox
September 09, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
Stellantis Recalls 1.46M Vehicles Globally Over Safety Software Flaw: Details
September 09, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
STLA
FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment
September 09, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
RZLT
What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?
September 09, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
INBS
Top Realtor Agent in Prescott, AZ, Reflects on Memorable Business Mistakes and Lessons Learned
September 09, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
FDA Rejection Of MDMA Could Fuel Black Market Demand, Warns CEO Of Women's Psychedelic Platform SetSet
September 07, 2024
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.